The host- Julie Rovner KHN
Well being care was a recurring theme all through President Joe Biden’s 2023 State of the Union deal with on Capitol Hill this week. He took a victory lap on latest accomplishments like capping prescription drug prices for seniors on Medicare. He urged Congress to do extra, together with making everlasting the boosted insurance coverage premium subsidies added to the Reasonably priced Care Act in the course of the pandemic. And he sparred with Republicans within the viewers — who jeered and referred to as him a liar — over GOP proposals that may lower Medicare and Social Safety.
In the meantime, abortion rights advocates and opponents are anxiously awaiting a federal courtroom choice out of Texas that would end in a nationwide ban on mifepristone, considered one of two medicine utilized in treatment abortion.
This week’s panelists are Julie Rovner of KHN, Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Sarah Karlin-Smith of the Pink Sheet.
Panelists
Rachel Cohrs Stat Information @rachelcohrs Learn Rachel’s tales Sarah Karlin-Smith Pink Sheet @SarahKarlin Learn Sarah’s tales Alice Miranda Ollstein Politico @AliceOllstein Learn Alice’s tales
Among the many takeaways from this week’s episode:
- President Joe Biden’s State of the Union deal with emphasised latest victories in opposition to excessive well being care prices, like Medicare protection caps on insulin and out-of-pocket caps on prescription drug spending. Biden’s energetic, casual change with lawmakers over potential cuts to Medicare and Social Safety appeared to steal the present, although the political struggle over slicing prices in these entitlement packages is rooted in a key query: What constitutes a “lower”?
- Biden’s requires bipartisanship to increase well being packages like pandemic-era subsidies for Reasonably priced Care Act well being plans are anticipated to conflict with conservative calls for to slash federal authorities spending. And final 12 months’s Senate fights reveal that typically the opposition comes from inside the Democratic Occasion.
- Whereas some abortion advocates praised Biden for vowing to veto a federal abortion ban, others felt he didn’t discuss sufficient in regards to the looming challenges to abortion entry within the courts. A choice is anticipated quickly in a Texas courtroom case difficult the long run use of mifepristone. The Trump-appointed decide’s choice may ban the drug nationwide, which means it will be barred even in states the place abortion continues to be authorized.
- The FDA is on the heart of the abortion tablet case, which challenges its approval of the drug many years in the past and will set a precedent for authorized challenges to the approval of different medicine. In different FDA information, the company just lately modified coverage to permit homosexual males to donate blood; introduced new meals security management in response to the child system disaster; and kicked again to Congress a query of the way to regulate CBD, or cannabidiol, merchandise.
- In drug pricing, the top-selling pharmaceutical, Humira, will quickly attain the top of its patent, which is able to provide a telling have a look at how competitors influences the value of biosimilars — and the issues that stay for lawmakers to resolve.
Additionally this week, Rovner interviews Kate Baicker of the College of Chicago a couple of new paper offering a potential center floor within the effort to determine common medical insurance protection within the U.S.
Plus, for “further credit score,” the panelists recommend well being coverage tales they learn this week they suppose it is best to learn, too:
Julie Rovner: The New York Instances’ “Do not Let Republican ‘Choose Consumers’ Thwart the Will of Voters,” by Stephen I. Vladeck
Alice Miranda Ollstein: Politico’s “Mpox Is Simmering South of the Border, Threatening a Resurgence,” by Carmen Paun
Sarah Karlin-Smith: KHN’s “Choices by CVS and Optum Panicked 1000’s of Their Sickest Sufferers,” by Arthur Allen
Rachel Cohrs: ProPublica’s “UnitedHealthcare Tried to Deny Protection to a Chronically In poor health Affected person. He Fought Again, Exposing the Insurer’s Inside Workings,” by David Armstrong, Patrick Rucker, and Maya Miller
Additionally talked about on this week’s podcast:
|
|
